This study aimed to evaluate the nutritional status of patients with cancer in palliative care and to examine the interrelationship between objective and subjective nutritional assessment measures. Patients' nutritional status in a palliative care unit of a Malaysian government hospital and a hospice facility were assessed using anthropometric measurements, weight loss at 1/6 months, and the scored patient-generated subjective global assessment (PG-SGA). Moderate-to-severe malnutrition was observed in a range from 31% to 69% using both measurements. Common nutritional impact symptoms were pain, xerostomia, and anorexia. Patient-generated subjective global assessment scores were significantly correlated with anthropometric measurements (P < .050). The PG-SGA is equally informative as objective indicators and is recommended as a quickly applied tool for nutritional status assessment of patients with cancer in palliative care.
Introduction
Malnutrition is a common observation in patients with advanced cancer. The prevalence of malnutrition in patients with cancer is reported to range from 8% to 84%, but it differs widely on the methods used for its assessment. 1, 2 It is multifactorial in nature and often as the outcome of host or tumor interactions and disease treatment involving increased energy expenditure and requirements. [3] [4] [5] [6] Depletion of nutritional reserves and significant weight loss subsequently leads to increased morbidity, decreased quality of life, and shorter duration of survival in patients with cancer. 3, 7 In the context of patients with cancer in palliative care, cure is no longer an expected outcome, and they are typically in their last 3 to 6 months of life. 8 Supportive palliation along with optimal nutrition care have been identified as having an essential role in improving the quality of life and overall clinical course of patient's with advanced cancer. [9] [10] [11] Several indicators for nutritional assessment of patients with cancer have been established. The common objective markers are anthropometric measurements (percentage body weight loss, body mass index [BMI], mid-upper-arm circumference [MUAC] , mid-upper-arm muscle circumference [MUAMC] , and skinfolds measurement), laboratory data (serum albumin and transferrin), and dietary intake while the subjective global assessment (SGA) and patient-generated subjective global assessment (PG-SGA) provide subjective information on nutritional status. Subjective evaluation of a patient's nutritional status is the oldest and most widely used method. 12 This method is easy, noninvasive, and cost-effective. 13 The scored PG-SGA is a modified tool of the original validated nutrition assessment tool SGA that has been recommended for use in patients with cancer. 3, 13, 14 The ideal instrument for nutritional assessment should be sensitive, accurate, reproducible by various observers, relevant in health and illness, applicable to all patients with cancer and cost-effective. 7 In addition, the ultimate clinical utility of any method of nutritional assessment lies in its ability to assess the risk of morbidity and mortality related to malnutrition, to identify causes and consequences of malnutrition, and to predict that the patient will benefit from supplemental nutrition. 15 However, no single index of nutrition can fully characterize a patients' nutritional status. 16, 17 The objective of the current study is to evaluate the nutritional status of patients with cancer in palliative care using objective and subjective nutritional assessments and to determine potential interrelationships between the methods.
Methods

Selection of Patients
Between January and April 2005, all consecutive, mentally alert, and ambulatory patients with cancer admitted as inpatients and outpatients at a palliative care unit of a Malaysian government hospital and a nongovernmental hospice facility were considered eligible to participate. Caregivers served as proxy respondents if the patient was unable to complete the questionnaire. Exclusion criteria included nonambulatory patients who had severe edema or ascites, were on enteral or parenteral nutrition support, terminally ill with metastasis, and secondary cancers. Readmitted patients were not assessed a second time. This study was approved by the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia Ethics Committee, the palliative and hospice care managements, and informed consent was obtained from all patients prior to data collection.
Data Collection
Nutritional status was assessed by 2 different methods (1) anthropometric measurements that were BMI, MUAC, triceps skinfold (TSF) thickness, MUAMC, and the percentage change in body weight within 1 month or 6 months and (2) the scored PG-SGA tool.
Anthropometry
The patients were weighed without shoes on a TANITA model floor scale (HD-312; Tanita Health Equipment Ltd, Tokyo, Japan). Height was measured in the standing position using a SECA microtoise tape (206; Vogel and Halke GmbH & Co, Hamburg, Germany). Body mass index was calculated using the following formula: BMI ¼ weight (kg)/height 2 (m 2 ). A fiber flexible tape was used to measure the MUAC, and TSF was measured with a skinfold caliper (Plicometro; Gima SpA, Bologna, Italy) using the procedures described by Gibson. 18 Duplicate measurements were taken, and the average of the 2 was used for calculation of MUAMC and TSF. Mid-upper-arm muscle circumference was calculated using the formula: MUAMC ¼ MUAC (cm) À [0.3142 Â TSF (mm)]. 19 
Patient-Generated Subjective Global Assessment
Slight modifications, such as the body weight in pounds was changed to metric form and corticosteroids drugs (dexamethasone) were added in the scoring for metabolic stress, were made on the PG-SGA questionnaire (Appendix). 14 The first 4 sections of this instrument (weight history, food intake, nutrition impact symptoms, and functional capacity) were completed by the patient using a check box format. Three clinicians and 1 nurse were responsible for completing the remaining questions, which covered all relevant diagnoses, evaluation of metabolic stressors such as sepsis, neutropenic fevers, biologic response to modifier therapy, use of corticosteroids, and finally the physical examination including loss of subcutaneous fat (triceps region and midaxillary line at the level of the lower ribs), muscle wasting (temporal areas, deltoids, and quadriceps with a loss of bulk and tone by palpation), and edema (ankle or sacral) or ascites. Each of them was trained to perform the PG-SGA using case presentations as adopted from Detsky et al 13 and Ottery. 14 For each component of the PG-SGA, a score ranging from 0 to 4 was given depending on the impact on nutritional status. Typical total scores range from 0 to 35 with a higher score (!9), reflecting a greater risk of malnutrition and a critical need for nutrition intervention. After the patient and clinician assessments were completed, a nutritional staging was given: (a) well nourished, (b) moderately malnourished, or (c) severely malnourished.
Statistical Analysis
Statistical Package for the Social Science (SPSS) for Windows, PC version, 15.0, was used for the statistical analyses. Pearson's correlation was applied to determine the relationship between PG-SGA scores and the objective nutritional variables, while 1-way analysis of variance (ANOVA) test was performed for differences in objective nutritional indices among the 3 categories of PG-SGA. A Bonferroni post hoc multiple comparison test was applied to further investigate significant differences between PG-SGA ratings. Effect size (eta squared) was manually calculated to examine the magnitude of difference and interpreted by Cohen's guidelines. 22 Assumption testing of these parametric statistical procedures was examined, and a statistical probability level of P < .050 was considered significant.
Results
A total of 58 patients with advanced cancers were recruited into this study. Table 1 presents sociodemographic, disease, and anthropometric characteristics of patients. Majority of the patients were of Chinese origin, and approximately 74.0% of these patients were actively undergoing surgery, radiotherapy, chemotherapy, or other alternative traditional treatments (given alone or in combination). Sixty-seven percentage of patients were prescribed with opioid analgesic drugs, such as codeine (for mild-to-moderate pain), morphine (for severe pain), and other painkiller medications (tramadol, methadone, pethidine, and buprenorphine). Table 2 depicts the nutritional status of patients according to various anthropometric nutritional and PG-SGA indicators.
Nutritional Status
As defined by BMI, slightly over half (55.2%) had normal BMI while 18 patients (31.0%) had chronic energy deficiency (stages I, II, and III). Six patients (10.3%) were classified as overweight and 2 as obese (both patients with female breast cancer). The overweight patients were diagnosed as having cancer of the pancreas, lung, nasopharynx, and lymphoma, with 1 case each, respectively.
Loss of subcutaneous fat was identified among 55% of the patients as indicated by triceps skinfold (TSF) measurements below the fifth percentile of the reference. Based on the midupper-arm circumference (MUAC), about two thirds of the patients showed no signs of wasting. Mild-to-moderate wasting was observed in 18 patients (31.0%), while only 2 patients (3.4%) exhibited extreme wasting. Muscle wasting indicating low protein reserves was found in 22 patients (37.9%). Eleven patients (19.0%) had both protein and subcutaneous fat loss. Weight loss classification revealed that an equal proportion of patients (27.6%) was in the category of weight loss 5% (1 month)/ 10% (6 months) and weight loss >5% (1 month)/ >10% (6 months), respectively.
Patient-Generated Subjective Global Assessment Rating
Patient-generated subjective global assessment rated 31.0% of the patients were ''well nourished,'' 50.0% as ''moderately malnourished,'' and 19.0% as ''severely malnourished.'' There is a significant linear trend in PG-SGA scores from well nourished (7.72 + 5.60) to severely malnourished (21.36 + 4.97). The most frequent nutrition impact symptoms were pain (55.2%), followed by xerostamia (44.8%), anorexia (36.2%), and constipation (31.0%). The other factors that impede food intake were problems with chewing and swallowing (25.9%), vomiting (25.9%), nausea (24.1%), diarrhea (19.0%), mouth soreness (15.5%), dysgeusia (13.8%), early satiety (11.0%), and dysnomia (1.7%). Majority of the patients (41.4%) have 3 to 4 nutrition impact symptoms at the same time.
Interrelationship Between Both Objective and Subjective Measures
A 1-way between-stages ANOVA indicated that there was a statistically significant difference at the P < .050 level in anthropometric measures for the 3 PG-SGA stages ( Table 3) . Despite reaching statistical significance, the actual difference in mean anthropometric nutritional values between the PG-SGA stages was large with a minimum of eta squared of 0.14. Post hoc comparisons using the Bonferroni test further reflected that the mean MUAC and MUAMC values were significantly different across PG-SGA stages.
The relationship between the PG-SGA score and the objective nutritional variables was presented in Table 3 . Both MUAC and TSF showed moderate, negative correlation between these 2 and PG-SGA score variables (r ¼ À.32, n ¼ 58, P < .050), with low reading of anthropometric measures associated with higher scores of PG-SGA.
Clinical Correlations Among Nutrition Impact Symptoms
As reported in Table 4 , anorexia is moderately correlated with problems of chewing and swallowing. Likewise, nausea has moderate correlation with vomiting and dysgeusia, xerostamia with mouth sores and early satiety, and finally dysnomia with dysgeusia.
Discussion
Overall, the percentage of malnutrition in this study ranged between 31.0% and 69.0% according to objective and subjective nutritional indicators. Although both nutritional assessment methods are used to define nutritional status, 3, 7, 13, 23 there is still no consensus on which is the most appropriate to be applied in a specific palliative care setting. Weight loss was found to be a dominant characteristic of patients with poor nutritional status. A majority of patients having weight loss and about one-third patients were observed with severe weight loss of >5% in 1 month. Continuous weight loss has been shown to be a good predictor of negative complications and as part of the classical causes of cachexia. 24, 25 Interestingly, this study has also discovered that a majority of patients with advanced cancer had normal-to-high BMI values as reported similarly by other studies. 25, 26 Most of the patients with cancer appear to die with normal BMI status despite significant weight loss. 25 This may due to precancer diagnosis of obesity. Overweight and obesity appear to be significant risk factors for developing cancer as justified by World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) 17 or perhaps by itself is a poor indicator of advanced cancer patient's nutritional status.
Triceps skinfold thickness provides an index of body fat stores, while MUAMC provides a measure of muscle mass and protein reserves. These 2 measurements are frequently used in clinical settings to assess protein energy malnutrition in patients. 21 However, a limited reference database and absence of correlation factors for age, hydration status, and physical activity present limiting confounders. 27 Therefore, TSF and MUAMC measurements of this small group of patients should be interpreted cautiously as the reference used is not obtained locally.
The PG-SGA tool is well established and validated with other objective nutritional measurements. 3, 28, 29 High agreement between physician, nurse, and dietitian for the overall subjective nutritional classification has also been highlighted, and patients were found having no problem in completing the PG-SGA. 30 Our study does not provide a proper validation of the tool, but the initial findings showed that the scored PG-SGA is an undoubted convenient choice of nutritional status evaluation as it was significantly correlated with anthropometric measurements. In our experience of assessment, the average time required to completing the PG-SGA by patient and responsible evaluator was 5 to 15 minutes. This suggests that the tool is practical to be used especially in busy palliative care units and often with fewer human resources. 14 However, a finding difficult to interpret is that a few anthropometric nutritional values such as TSF, weight loss in 1 or 6 months, and BMI were not significantly different across the PG-SGA stages. This may result in ''floor effect'' of basic anthropometric measurements as well as poor recall of weight in 1 or 6 months. Regular practice and training of these measurements and accurate weight recall by the patient are essential to minimize the undesirable effect. 18 This may also reinstate that BMI is not as sensitive as other more vigorous nutritional assessments, and further evaluation of this indicator in cancer patients is recommended. 29, 31 Combination of 3 or more nutrition impact symptoms as experienced by the patients may be the reasons why a higher scored PG-SGA of patients was obtained particularly for the severely malnourished patients. These symptoms may be the treatment induced or as a result of disease progression. Early studies reported common symptoms that adversely affect food intake of patients with cancer were anorexia, nausea, pain, and xerostamia. 25, 32, 33 Our study also reported that these symptoms are among the frequent side effects that affected patients' nutritional status. The moderate clinical correlation among nutrition impact symptoms gives us additional information to be taken care of when working with advanced cancer patients. Anorexia or better known as loss of appetite is likely due to chewing or swallowing difficulty in these patients. In contrast, Bovio et al 33 highlighted that this difficulty does not affect nutritional status, yet we found entirely the opposite. Nausea and vomiting have been acknowledged as important symptoms to deal with and have a great influence on the appetite and diet intakes of patients with cancer. 33 The association between nausea with vomiting and dysgeusia was confirmed by our data. Xerostamia is also profoundly affected mouth soreness and early satiety in our study. The possible causes of this symptom are damage of the salivary glands during oral cavity radiotherapy, use of antidepressant, diuretic or morphine drugs, and dehydration as cited by Bovio et al. 33 A limitation of this work was the relatively small sample size that may not allow the generalizability of the results to the nutritional status of patients with cancer in other palliative cares of the country. In addition, exclusion of objective biochemical parameters such as inflammatory activity biomarkers (serum pre-albumin and high sensitivity C-reactive protein) also restricted a more comprehensive evaluation of the methods used and further understanding of the etiology of malnutrition in these patients.
Many advanced patients with cancer have detectable malnutrition according to various nutritional indicators. A larger prospective study is suggested to confirm the prevalence of malnutrition in patients with cancer in palliative care. Addressing patient's nutrition impact symptoms can help both their nutritional status and quality of life. Therefore, dietitians, nutritionists, or other health-related professions in palliative care center should initiate appropriate nutritional services particularly for those identified as malnourished with symptoms. In our experience, the PG-SGA is a quick and easily applied technique to assess the nutritional status of patients with cancer and accordingly stage them into well nourished, moderately malnourished, and severely malnourished categories. This instrument correlates significantly with objective nutritional indices and thus indicates that it is a good alternative to anthropometric measurements and could be used routinely in busy palliative care settings.
